Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05002608 · ClinicalTrials.gov registry record · NA

Virtual Health Insurance Navigation Pilot Program for Colorectal Survivors

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
36
Enrollment target

NCT05002608: Completed NA study, sponsored by Massachusetts General Hospital.

NCT05002608 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05002608, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
36 participants
Enrollment target

Study Summary

This trial aims to assess the feasibility and acceptability of colorectal survivors approached and engaged in HINT and aims to assess the preliminary efficacy of HINT to improve 1) health insurance literacy and 2) financial burden related to medical cost concerns colorectal survivors. The study investigators propose that, compared to the control arm (who will receive a health insurance information guide, but will not receive the navigation intervention), participants in the HINT intervention arm will have improved health insurance literacy and decreased financial distress related to medical costs.

Primary Outcome

10-point (1-10; 1= least helpful and 10= most helpful) scale rating of program quality, including the following (higher scores indicate higher levels of acceptability)-

Interventions

  • BEHAVIORAL Health Insurance Navigation Tools Program

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2021-11-01
Est. Completion 2023-07-30
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT05002608 record still lists

NCT05002608 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Health Insurance Navigation Tools Program is the first listed.

NCT05002608 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05002608 about?

NCT05002608 is a clinical study titled "Virtual Health Insurance Navigation Pilot Program for Colorectal Survivors". This trial aims to assess the feasibility and acceptability of colorectal survivors approached and engaged in HINT and aims to assess the preliminary efficacy of HINT to improve 1) health insurance literacy and 2) financial burden related to medical cost concerns colorectal survivors. The study inve...

What is the current status of trial NCT05002608?

This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2021-11-01. Estimated completion is 2023-07-30.

What interventions are being tested in trial NCT05002608?

The interventions under investigation include: Health Insurance Navigation Tools Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT05002608?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05002608's enrollment target sits among peer trials

36 1541st of 2000 higher than 437 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00929006 · 36 participants · Early Phase 1

    Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

  • NCT01891318 · 36 participants · Phase 1

    Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

  • NCT02291848 · 36 participants · Phase 1

    Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

  • NCT02366819 · 36 participants · Phase 4

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05002608, the US trial registry maintained by the National Library of Medicine. NCT05002608 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.